That obesity and hepatic steatohepatitis are associated with impaired insulin clearance is demonstrated by the repression of hepatic CEACAM1 expression by high-fat (HF) intake [134] via a peroxisome-proliferator-activated receptor α (PPARα)-dependent mechanism [135]. Here, CEACAM1 is linked to obesity due to melanocortin 4 receptor deficiency.